MEDICARE CHARTING GUIDELINES - HealthInsight

presence of extravasation or infiltration at intravenous (IV) site. signs/symptoms of magnesium toxicity, worsening pre-signs or symptoms of eclampsia, or progression of labor . periodic urine assessment for protein (if applicable) vaginal bleeding. tocography and FHR (with antepartum or intrapartum use) ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download